|
2024
|
G/S
|
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous syst... |
|
|
G/S
|
A full line of medicated and pharmaceutical preparations for use in connection with humans; dieta... |
|
|
G/S
|
medical information services, namely, providing information on the topics of muscular dystrophy a... |
|
|
G/S
|
Medical information services, namely providing information on the topics of hemophilia and treatm... |
|
|
G/S
|
Providing information on the topic of cancer; online information services, namely providing a web... |
|
|
G/S
|
Providing medical information in the field of sickle cell disease |
|
|
G/S
|
Medical information services, namely, providing information on the topic of hemophilia and treatm... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurodegenerative, nerve, neuromuscular and brai... |
|
|
G/S
|
Pharmaceutical preparations. |
|
|
G/S
|
Pharmaceutical preparations for treatment of hemophilia. Medical information services, namely, pr... |
|
|
G/S
|
medical information services, namely providing information on the topic of muscular dystrophy and... |
|
|
G/S
|
Downloadable mobile application for providing information on the topic of migraine, treatment of ... |
|
|
G/S
|
Downloadable mobile application for providing information on the topic of migraine and managing t... |
|
|
G/S
|
Medical information services, namely, providing information on the topic of Alopecia Areata and t... |
|
2023
|
Invention
|
Glp-1 receptor agonists and uses thereof.
Provided herein are 6-carboxylic acids of benzimidazol... |
|
|
Invention
|
Human cytomegalovirus gb polypeptide.
The present invention relates to polypeptides and cytomega... |
|
|
Invention
|
Compounds for the activation of ampk. Described herein are compounds of Formula I, wherein the va... |
|
|
Invention
|
Vaccination against pneumoccocal and covid-19 infections. The invention relates to vaccination of... |
|
|
Invention
|
Combination vaccines against coronavirus infection, influenza infection, and/or rsv infection. Th... |
|
|
Invention
|
Compounds for the treatment of cancer. The invention relates to 4-((6-(2,2-Difluoroethyl)-8-(2-hy... |
|
|
Invention
|
Use of patatin-like phospholipase domain-containing protein 3 compounds. The present invention is... |
|
|
Invention
|
Patatin-like phospholipase domain-containing protein 3 (pnpla3) modifiers. The present invention ... |
|
|
Invention
|
Hsd17b13 inhibitors and/or degraders. Described herein are compounds of Formula I, wherein the va... |
|
|
Invention
|
Improved host cells for aav vector production. The disclosure provides improved host cells for pr... |
|
|
Invention
|
H-pyrazolo-pyridine and-pyrimidine compounds. This disclosure relates to compounds of Formula (I)... |
|
|
Invention
|
Combination of talazoparib and enzalutamide in the treatment of metastatic castration-resistant p... |
|
|
Invention
|
Immunogenic compositions comprising an rsv f protein trimer. The invention relates to aqueous and... |
|
|
Invention
|
Methods of treatment with ifnß antibodies. The invention provides methods for treating a patient ... |
|
|
Invention
|
B-cell maturation antigen (bcma) anti-idiotypic antibodies.
Provided herein are anti-idiotype an... |
|
|
Invention
|
Heterocyclic sik inhibitors. 122233141414121-4123536221214413s1314627714813s13133)linear or branc... |
|
|
Invention
|
B-cell maturation antigen (bcma) anti-idiotypic antibodies. Provided herein are anti-idiotype ant... |
|
|
Invention
|
Novel sik inhibitors.
A compound of formula I having the structure:
A compound of formula I ha... |
|
|
Invention
|
Lipid nanoparticles. The present disclosure relates to lipids, lipid nanoparticles and formulatio... |
|
|
Invention
|
Coaxial flow device for nanoparticle preparation and manufacturing equipment including such devic... |
|
|
Invention
|
Treatment regimens with anti-cd47 / anti-pd-l1 bispecific antibodies. The present disclosure prov... |
|
|
Invention
|
Dosage regimens of estrogen receptor degraders. Disclosed herein are methods for treating cancer ... |
|
|
Invention
|
Methods of treating uveal melanoma. Provided herein is a combination therapy and methods of using... |
|
|
Invention
|
Computerized decision tool for sars-cov-2 variants prediction. Technology is disclosed for a meth... |
|
|
Invention
|
Sirp alpha fusion protein and anti-cd38 antibody combination therapies. Dosing regimens and metho... |
|
|
Invention
|
Methods for purification of aav vectors by anion exchange chromatography. The present disclosure ... |
|
|
Invention
|
Anti- il27r antibodies and methods of use thereof.
The present invention relates to antibodies t... |
|
|
Invention
|
Solid state forms of (s)-2-(((s)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-n-(1-(2-me... |
|
|
Invention
|
Novel acc inhibitors.
A compound having the structures:
A compound having the structures:
... |
|
|
Invention
|
Cd1a antibodies and uses thereof.
Antibodies, and antigen-binding fragments thereof, that specif... |
|
|
Invention
|
Cells and method of cell culture.
The invention relates to a method of cell culture where the ce... |
|
|
Invention
|
Anti-bmp9 antibodies and methods of use thereof.
Antibodies, and antigen-binding fragments there... |
|
|
Invention
|
Antibodies specific for cd47, pd-l1, and uses thereof.
Antibodies that specifically bind to CD47... |
|
|
Invention
|
Anti-tl1a antibodies and methods of use thereof.
The present invention discloses an isolated ant... |
|
|
Invention
|
Sulfonyl amide derivatives for the treatment of abnormal cell growth.
The present invention rela... |
|
|
Invention
|
Multispecific antibodies and uses thereof.
The present invention relates to antibodies that spec... |
|
|
Invention
|
Anti-e-selectin antibodies, compositions and methods of use.
The invention provides antibodies, ... |
|
|
Invention
|
Colorimetric detection of nucleic acid amplification.
Colorimetry is used to detect amplificatio... |
|
2022
|
Invention
|
Methods of protecting rna.
The present disclosure provides methods of protecting ribonucleic aci... |
|
2021
|
Invention
|
Solid forms of an eif4e inhibitor.
The present invention relates to solid forms of 7-(5-chloro-2... |
|
|
Invention
|
Solid forms of a cdk2 inhibitor.
The invention relates to solid forms of (1R,3S)-3-[3-({[3-(meth... |
|
|
Invention
|
Pill |
|
|
Invention
|
External medication packaging |
|
|
Invention
|
Improved pharmaceutical compositions containing adeno-associated viral vector.
The present inven... |
|
|
Invention
|
Benzimidazole derivatives and their use as inhibitors of itk for the treatment of skin disease.
... |
|
|
Invention
|
Pyrido[2,3-d]imidazole derivatives and their use as inhibitors of itk for the treatment of skin d... |
|
|
Invention
|
Hilic uplc-ms method for separating and analyzing intact adeno-associated virus capsid proteins. ... |
|
|
Invention
|
Methods of identifying a tumor that is sensitive to treatment with talazoparib and methods of tre... |
|
|
Invention
|
Polymorph of (1s,2s,3s,5r)-3-((6-(difluoromethyl)-5-fluoro-1,2,3,4-tetrahydroisoquinolin-8-yl)oxy... |
